CRISPR/Cas9 nanoeditor of double knockout large fragments of E6 and E7 oncogenes for reversing drugs resistance in cervical cancer
Abstract Drug resistance of tumor cells is always a headache problem in clinical treatment. In order to combat chemotherapy-resistance in cervical cancer and improve treatment effect, we design a CRISPR/Cas9 nanoeditor to knock out two key oncogenes E6 and E7 that lead to drug tolerance. Meanwhile,...
Main Authors: | Xianhuang Li, Mingming Guo, Bei Hou, Bin Zheng, Zhiyun Wang, Mengqian Huang, Yanan Xu, Jin Chang, Tao Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-08-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-021-00970-w |
Similar Items
-
The CRISPR/Cas9 induces large genomic fragment deletions of MSTN and phenotypic changes in sheep
by: Yi DING, et al.
Published: (2020-04-01) -
Genome Editing in Cotton with the CRISPR/Cas9 System
by: Wei Gao, et al.
Published: (2017-08-01) -
Designer nucleases to treat malignant cancers driven by viral oncogenes
by: Tristan A. Scott, et al.
Published: (2021-01-01) -
On-Target CRISPR/Cas9 Activity Can Cause Undesigned Large Deletion in Mouse Zygotes
by: Alexey Korablev, et al.
Published: (2020-05-01) -
Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems
by: Fei Zhang, et al.
Published: (2019-06-01)